Trademark: 88203331
Word
KYMERA THERAPEUTICS
Status Date
Monday, August 14, 2023
Filing Date
Thursday, November 22, 2018
Published for Opposition
Tuesday, October 8, 2019
Abandoned Date
Monday, August 14, 2023
5 House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
42 Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Assays and reagents for use in scientific and biomedical research; Clinical studies; Preclinical and clinical development of therapeutic products
The mark consists of several geometric designs that form the basic elements of an animal face, to the right of the design appears the wording "KYMERA THERAPEUTICS" in capital stylized letters.
Color is not claimed as a feature of the mark.
"THERAPEUTICS"
Aug 14, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 14, 2023
Abandonment - No Use Statement Filed
Jan 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2023
Sou Extension 4 Granted
Jan 11, 2023
Sou Extension 4 Filed
Jan 11, 2023
Sou Teas Extension Received
Jul 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2022
Sou Extension 3 Granted
Jul 12, 2022
Sou Extension 3 Filed
Jul 12, 2022
Sou Teas Extension Received
Jan 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 11, 2022
Sou Extension 2 Granted
Jan 11, 2022
Sou Extension 2 Filed
Jan 11, 2022
Sou Teas Extension Received
Jul 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2021
Sou Extension 1 Granted
Jul 12, 2021
Sou Extension 1 Filed
Jul 12, 2021
Sou Teas Extension Received
Jan 12, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 3, 2020
Ttab Release Case To Trademarks
Dec 3, 2020
Opposition Terminated No. 999999
Nov 2, 2020
Opposition Dismissed No. 999999
Nov 14, 2019
Opposition Instituted No. 999999
Nov 7, 2019
Opposition Papers Received At Ttab
Oct 8, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 8, 2019
Published For Opposition
Sep 18, 2019
Notification Of Notice Of Publication E-Mailed
Sep 5, 2019
Assigned To Lie
Sep 3, 2019
Approved For Pub - Principal Register
Aug 24, 2019
Teas/Email Correspondence Entered
Aug 23, 2019
Correspondence Received In Law Office
Aug 23, 2019
Teas Response To Office Action Received
Feb 26, 2019
Notification Of Non-Final Action E-Mailed
Feb 26, 2019
Non-Final Action E-Mailed
Feb 26, 2019
Non-Final Action Written
Feb 25, 2019
Assigned To Examiner
Dec 13, 2018
Notice Of Design Search Code E-Mailed
Dec 12, 2018
New Application Office Supplied Data Entered
Nov 26, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
